News Focus
News Focus
Followers 0
Posts 59
Boards Moderated 0
Alias Born 01/24/2017

Re: scoobey-do post# 3716

Sunday, 01/19/2020 7:49:09 AM

Sunday, January 19, 2020 7:49:09 AM

Post# of 4176
Ph 2 is going well. The science is solid.

Another company have success with the science just underscores that PDT treatments are the next huge thing in cancer treatments.

Theralase Researchers Receive Recognition for Recent Scientific Publications November 27, 2019

The recognition from three scientific institutes emphasizes the strong science-based technology that the Company possesses, verifying that Theralase’s Ruthenium-based PDCs are leading the pack in terms of performance of Photo Dynamic Therapy (“PDT”) metal based PDCs to become the next viable option for treating various cancers, suggesting a major change in the way various cancers are treated in the future.

The review article, titled “Metal-Based photosensitizers for photodynamic therapy – the future of multimodal oncology?”, is available online at www.sciencedirect.com and will be published in a special issue of Current Opinion in Chemical Biology entitled Next Generation Therapeutics, Volume 56, June 2020. The article verifies that the Company’s lead PDC TLD-1433 has strong scientific support, is highly advanced in clinical studies and may become the next “gold standard” cancer treatment.

https://theralase.com/pressrelease/theralase-researchers-receive-recognition-for-recent-scientific-publications/



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TLTFF News